Clinical Trial Update: An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 escalating-dose study evaluated safety, tolerability, and pharmacokinetics of LNK 754 in elderly volunteers and individuals with mild Alzheimer's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LNK 754

Snippet

Sponsor: Link Medicine Corporation | Conditions: Mild Alzheimer's Disease | Phase 1 | Status: COMPLETED